Aurinia Pharmaceuticals, Inc. (AUPH)
15.61
+0.14
(+0.90%)
USD |
NASDAQ |
Apr 02, 16:00
15.70
+0.09
(+0.58%)
Pre-Market: 20:00
Aurinia Pharmaceuticals Shareholders Equity (Quarterly) : 581.33M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Xenon Pharmaceuticals, Inc. | 581.76M |
| Oncolytics Biotech, Inc. | -3.799M |
| Edesa Biotech, Inc. | 13.95M |
| Lexaria Bioscience Corp. | 4.913M |
| ProMIS Neurosciences, Inc. | -1.259M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 770.59M |
| Total Liabilities (Quarterly) | 189.26M |
| Debt to Equity Ratio | 0.1287 |
| Current Ratio | 5.249 |
| Net Debt Paydown Yield | 0.12% |